Actinium Pharmaceuticals Correlations

ATNM Stock

USD 1.41 0.03 2.08%

The current 90-days correlation between Actinium Pharmaceuticals and Mink Therapeutics is 0.17 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Actinium Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Actinium Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Actinium Pharmaceuticals Correlation With Market

Average diversification

The correlation between Actinium Pharmaceuticals and DJI is 0.18 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Actinium Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Actinium Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

To learn how to invest in Actinium Stock, please use our How to Invest in Actinium Pharmaceuticals guide.

Moving together with Actinium Stock

0.69	ME	23Andme Holding	Pair Corr
0.74	VALN	Valneva SE ADR	Pair Corr
0.61	DNLI	Denali Therapeutics	Pair Corr
0.75	DNTH	Dianthus Therapeutics	Pair Corr
0.81	DRRX	Durect	Pair Corr
0.76	DTIL	Precision BioSciences	Pair Corr
0.69	VIGL	Vigil Neuroscience	Pair Corr
0.61	VINC	Vincerx Pharma	Pair Corr
0.65	VIRX	Viracta Therapeutics	Pair Corr
0.65	VRPX	Virpax Pharmaceuticals	Pair Corr
0.77	VTGN	VistaGen Therapeutics	Pair Corr

Moving against Actinium Stock

0.66	VCYT	Veracyte	Pair Corr
0.54	VCEL	Vericel Corp Ord	Pair Corr
0.53	DMAC	DiaMedica Therapeutics	Pair Corr
0.51	DRTS	Alpha Tau Medical	Pair Corr
0.46	VANI	Vivani Medical	Pair Corr
0.46	VERA	Vera Therapeutics	Pair Corr
0.44	SABSW	SAB Biotherapeutics	Pair Corr
0.31	DRUG	Bright Minds Biosciences	Pair Corr
0.61	DYAI	Dyadic International	Pair Corr
0.56	VSTM	Verastem Trending	Pair Corr
0.55	VTRS	Viatris	Pair Corr
0.54	VRNA	Verona Pharma PLC	Pair Corr
0.48	VTVT	vTv Therapeutics	Pair Corr
0.32	DVAX	Dynavax Technologies	Pair Corr

Related Correlations Analysis

	INKT	AFMD	IMGN	ADAP	SGMO	RIGL	FBIO	RVPH	CTIC	OCUP
INKT		0.71	-0.58	0.59	-0.09	-0.19	0.17	0.05	-0.32	0.74	INKT
AFMD	0.71		-0.57	0.67	-0.24	-0.54	0.13	-0.05	-0.4	0.69	AFMD
IMGN	-0.58	-0.57		-0.9	0.73	0.55	-0.07	-0.29	0.8	-0.83	IMGN
ADAP	0.59	0.67	-0.9		-0.72	-0.68	0.09	0.18	-0.85	0.76	ADAP
SGMO	-0.09	-0.24	0.73	-0.72		0.63	0.21	-0.57	0.87	-0.4	SGMO
RIGL	-0.19	-0.54	0.55	-0.68	0.63		-0.02	-0.11	0.59	-0.43	RIGL
FBIO	0.17	0.13	-0.07	0.09	0.21	-0.02		-0.22	0.2	0.35	FBIO
RVPH	0.05	-0.05	-0.29	0.18	-0.57	-0.11	-0.22		-0.34	0.09	RVPH
CTIC	-0.32	-0.4	0.8	-0.85	0.87	0.59	0.2	-0.34		-0.49	CTIC
OCUP	0.74	0.69	-0.83	0.76	-0.4	-0.43	0.35	0.09	-0.49		OCUP
	INKT	AFMD	IMGN	ADAP	SGMO	RIGL	FBIO	RVPH	CTIC	OCUP

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CTIC	+ 0.87	SGMO
CTIC	+ 0.8	IMGN
OCUP	+ 0.76	ADAP
OCUP	+ 0.74	INKT
SGMO	+ 0.73	IMGN
AFMD	+ 0.71	INKT

High negative correlations

ADAP	- 0.9	IMGN
CTIC	- 0.85	ADAP
OCUP	- 0.83	IMGN
SGMO	- 0.72	ADAP
RIGL	- 0.68	ADAP
IMGN	- 0.58	INKT

Risk-Adjusted Indicators

There is a big difference between Actinium Stock performing well and Actinium Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Actinium Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
INKT	1.74	(0.21)	0.00	(0.37)	0.00	0.00	4.05	(3.85)	12.30
AFMD	2.72	(0.89)	0.00	(0.46)	0.00	0.00	7.25	(7.86)	21.26
IMGN	5.45	2.82	1.07	1.60	1.44	(6.91)	8.32	(4.16)	141.41
ADAP	3.07	(0.93)	0.00	(0.61)	0.00	0.00	6.06	(5.43)	32.97
SGMO	6.58	1.42	0.31	0.47	4.71	(8.84)	24.14	(8.90)	50.57
RIGL	3.37	1.18	0.35	2.49	2.46	(4.19)	9.10	(4.39)	55.18
FBIO	3.61	0.07	0.03	0.15	4.47	(4.49)	9.19	(5.08)	26.13
RVPH	4.90	0.52	0.05	(0.40)	5.85	(5.64)	10.71	(9.86)	40.06
CTIC	3.53	1.50	0.60	10.62	0.91	(4.87)	5.30	(3.58)	85.60
OCUP	3.18	(0.81)	0.00	(1.57)	0.00	0.00	6.10	(5.84)	27.18

Actinium Pharmaceuticals Corporate Management

Bernie PMP	Executive Management	Profile
Qing Liang	VP Sciences	Profile
Madhuri MD	Vice Therapy	Profile
Lynn MBA	Chief Officer	Profile
Paul Esq	Vice Counsel	Profile
Jenny Hsieh	Chief Officer	Profile
Dr MS	VP Operations	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC